Phase 2 Trial of BRTX-100 in cLDD Continues to Generate Positive Preliminary Blinded Data
OrthoSpineNews
MAY 13, 2025
The following is breakdown of the percentage of subjects that had both a greater than 50% improvement in function, as measured by ODI, and a greater than 50% decrease in pain, as measured by VAS: Week Percentage of Subjects with a Greater than 50% improvement in Both ODI and VAS 2 0.0% 12 13.33% 26 46.15% 52 70.0%
Let's personalize your content